Axel Maibuecher

Axel Maibuecher serves as an Advisory Board Member for Ysios BioFund III and is a member of the investment committee for Ysios BioFund II. Previously, Axel held multiple positions at Novartis Institutes for BioMedical Research (NIBR), including Head of Business Development for the Europe region, and led the Business Development & Licensing for the Strategic Partnerships Team, as well as Search & Evaluation for Integrated Hospital Care.